THU-111-High efficacy and safety of the combination HCV regimen elbasvir and grazoprevir for 8 weeks in treatment-naive non-severe fibrosis HCVGT1b-infected patients: Final results of the STREAGER study

Autor:	Frederic Faure, Armand Abergel, François Bailly, Cecile Campos, Brigitte Chanteranne, Camille Teilhet, Maud Reymond, Christophe Hézode, Tran Albert, Marie Dodel, Jérôme Gournay, Vincent Di Martino, Leon Muti, Pol Stanislas, Véronique Loustaud-Ratti, Tarik Asselah, Bruno Pereira, Dominique Larrey, Didier Samuel, Benjamin Buchard, Géraldine Lamblin, I. Hubert
Rok vydání:	2019
Předmět:	Therapy naive medicine.medical_specialty Regimen Elbasvir Hepatology Grazoprevir business.industry Internal medicine medicine Severe fibrosis business Gastroenterology
Zdroj:	Journal of Hepatology. 70:e207
ISSN:	0168-8278
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bbdaaa01c0ae06a13fb55405f7c67834 https://doi.org/10.1016/s0618-8278(19)30386-x Zobrazit plný text záznamu Full Text from ScienceDirect